These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 27767989

  • 1. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    Anderson M, Xu F, Ou-Yang MH, Davis J, Van Nostrand WE, Robinson JK.
    J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989
    [Abstract] [Full Text] [Related]

  • 2. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 3. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM.
    J Neurosci; 2010 May 26; 30(21):7281-9. PubMed ID: 20505094
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO, Qiao F, Liu Y, Longley K, Feng S, Wang H.
    J Alzheimers Dis; 2017 May 26; 59(2):575-590. PubMed ID: 28598849
    [Abstract] [Full Text] [Related]

  • 5. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA.
    J Neurosci; 2010 Jun 16; 30(24):8180-9. PubMed ID: 20554868
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 7. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL.
    J Neurosci; 2017 Mar 01; 37(9):2449-2462. PubMed ID: 28137967
    [Abstract] [Full Text] [Related]

  • 8. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
    Nguyen TV, Hayes M, Zbesko JC, Frye JB, Congrove NR, Belichenko NP, McKay BS, Longo FM, Doyle KP.
    Acta Neuropathol Commun; 2018 Sep 24; 6(1):100. PubMed ID: 30249297
    [Abstract] [Full Text] [Related]

  • 9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 10. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec 23; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 11. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease.
    Zhu S, Wang J, Zhang Y, He J, Kong J, Wang JF, Li XM.
    CNS Neurosci Ther; 2017 Apr 23; 23(4):310-320. PubMed ID: 28191738
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.
    Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551
    [Abstract] [Full Text] [Related]

  • 13. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, Yang H, Feng N, Wang L, Wang X.
    J Alzheimers Dis; 2012 Jun 18; 29(2):379-91. PubMed ID: 22233765
    [Abstract] [Full Text] [Related]

  • 14. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH, Wang YR, Zhang T, Jiao SS, Liu YH, Zeng F, Li J, Yao XQ, Zhou HD, Zhou XF, Wang YJ.
    J Neurochem; 2016 Jul 18; 138(1):163-73. PubMed ID: 26991827
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S, Zhi Y, Li F, Huang S, Gao H, Han Z, Ge X, Li D, Chen F, Kong X, Lei P.
    J Neurol Sci; 2018 Apr 15; 387():6-15. PubMed ID: 29571873
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.
    J Alzheimers Dis; 2010 Apr 15; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [Abstract] [Full Text] [Related]

  • 19. Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease.
    Melief EJ, Cudaback E, Jorstad NL, Sherfield E, Postupna N, Wilson A, Darvas M, Montine KS, Keene CD, Montine TJ.
    J Neurosci Res; 2015 Sep 15; 93(9):1413-22. PubMed ID: 25824456
    [Abstract] [Full Text] [Related]

  • 20. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM, Muñoz-Manco JI, Ramírez-Pineda JR, Lamprea-Rodriguez M, Osorio E, Cardona-Gómez GP.
    Neuropharmacology; 2015 Jun 15; 93():134-45. PubMed ID: 25666032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.